References
- Eftimov F, van Schaik I. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options. Curr Opin Neurol 2013;26:496-502. https://doi.org/10.1097/WCO.0b013e328363bfa4
- Suanprasert N, Hanchaiphiboolkul S. Clinical characteristics of chronic inflammatory demyelinating polyradiculoneuropathy in diabetes patients. Neurology Asia 2017;22:227-234.
- Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc subcommittee of the American academy of neurology AIDS task force. Neurology 1991;41:617-618. https://doi.org/10.1212/WNL.41.5.617
- Odabasi Z, Joy JL, Claussen GC, Herrera GA, Oh SJ. Isaacs' syndrome associated with chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 1996;19:210-215. https://doi.org/10.1002/(SICI)1097-4598(199602)19:2<210::AID-MUS13>3.0.CO;2-Y
- Joint Task Force of the EFNS and the PNS. European federation of neurological societies/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European federation of neurological societies and the peripheral nerve society. J Peripher Nerv Syst 2005;10:220-228. https://doi.org/10.1111/j.1085-9489.2005.10302.x
- Miller TM. Differential diagnosis of myotonic disorders. Muscle Nerve 2008;37:293-299. https://doi.org/10.1002/mus.20923
- Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002;125:1887-1895. https://doi.org/10.1093/brain/awf178